Similarly, Aurora-B inhibitor treatment also showed profound growth inhibition and tumor regression in N-Myc-driven neuroblastoma, although the underlying mechanism of this finding remains unclear (39, 40). This evidence concerns the gene MYCN and neuroblastoma.